Federal
Expressing support for the designation of September 4, 2020, as "National Polycystic Kidney Disease Awareness Day", and raising awareness and understanding of polycystic kidney disease.
Source: Congress.gov ·
742 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
IV
116TH CONGRESS
2D SESSION
H. RES. 1142
Expressing support for the designation of September 4, 2020, as ‘‘National
Polycystic Kidney Disease Awareness Day’’, and raising awareness and
understanding of polycystic kidney disease.
IN THE HOUSE OF REPRESENTATIVES
SEPTEMBER 23, 2020
Mr. CLEAVER (for himself and Mr. LUETKEMEYER) submitted the following
resolution; which was referred to the Committee on Energy and Commerce
RESOLUTION
Expressing support for the designation of September 4,
2020, as ‘‘National Polycystic Kidney Disease Awareness
Day’’, and raising awareness and understanding of poly-
cystic kidney disease.
Whereas designating September 4, 2020, as ‘‘National Poly-
cystic Kidney Disease Awareness Day’’ will raise public
awareness and understanding of polycystic kidney dis-
ease, one of the most prevalent genetic kidney disorders,
which affects approximately 500,000 people in the United
States;
Whereas National Polycystic Kidney Disease Awareness Day
will help to foster an understanding of the impact poly-
cystic kidney disease has on individuals and their fami-
lies;
VerDate Sep 11 2014
23:21 Sep 23, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR1142.IH
HR1142
pamtmann on DSKBC07HB2PROD with BILLS
2
•HRES 1142 IH
Whereas polycystic kidney disease is a progressive, genetic
disorder of the kidneys that causes damage to the kid-
neys and the cardiovascular, endocrine, hepatic, and gas-
trointestinal organ systems;
Whereas polycystic kidney disease affects the health and fi-
nances of individuals, and equally affects individuals of
all ages, races, ethnicities, and sexes;
Whereas, of the individuals diagnosed with polycystic kidney
disease, approximately 10 percent have no family history
of the disease, with the disease developing as a sponta-
neous mutation;
Whereas there are very few treatments and no cure for poly-
cystic kidney disease, which is 1 of the 4 leading causes
of kidney failure in the United States;
Whereas almost 50 percent of individuals with polycystic kid-
ney disease experience kidney failure by age 60;
Whereas friends, loved ones, spouses, and caregivers of indi-
viduals with polycystic kidney disease can assist with the
challenges created by polycystic kidney disease, including
by helping such individuals maintain a healthy lifestyle
and make regular visits to their health care providers;
Whereas the severity of the symptoms of polycystic kidney
disease and limited public awareness of the disease may
cause individuals to forgo regular visits to their physi-
cians or avoid following the health recommendations of
their doctors, which experts suggest could help prevent
further complications should kidney failure occur;
Whereas individuals who have chronic, life-threatening dis-
eases like polycystic kidney disease may experience de-
pression;
VerDate Sep 11 2014
23:21 Sep 23, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR1142.IH
HR1142
pamtmann on DSKBC07HB2PROD with BILLS
3
•HRES 1142 IH
Whereas the PKD Foundation and its more than 35,000 pa-
tient and family advocates around the United States are
dedicated to—
(1) conducting research to find treatments and a
cure for polycystic kidney disease;
(2) fostering public awareness and understanding of
polycystic kidney disease;
(3) educating individuals and their families about
the disease to improve their treatment and care; and
(4) providing support, including by sponsoring the
annual ‘‘Walk for PKD’’, to raise funds for polycystic
kidney disease research, education, advocacy, and aware-
ness; and
Whereas, on September 4, 2020, the PKD Foundation
partnered with sister organizations in Canada, Australia,
and other countries to increase international awareness of
polycystic kidney disease: Now, therefore, be it
Resolved, That the House of Representatives—
1
(1) expresses support for the designation of
2
‘‘National Polycystic Kidney Disease Awareness
3
Day’’;
4
(2) supports the goals and ideals of National
5
Polycystic Kidney Disease Awareness Day to raise
6
public awareness and understanding of polycystic
7
kidney disease;
8
(3) recognizes the need for additional research
9
to find a cure for polycystic kidney disease; and
10
(4) encourages all people in the United States
11
and interested groups to support National Polycystic
12
VerDate Sep 11 2014
23:21 Sep 23, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR1142.IH
HR1142
pamtmann on DSKBC07HB2PROD with BILLS
4
•HRES 1142 IH
Kidney Awareness Day through appropriate cere-
1
monies and activities to promote public awareness of
2
polycystic kidney disease and to foster an under-
3
standing of the impact of the disease on individuals
4
and their families.
5
Æ
VerDate Sep 11 2014
23:21 Sep 23, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR1142.IH
HR1142
pamtmann on DSKBC07HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.